Literature DB >> 2472441

Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells.

N W Pearce1, A Spinelli, K E Gurley, S E Dorsch, B M Hall.   

Abstract

In DA rats grafted with PVG hearts, the injection of 1 ml of Wistar-Furth x DA)F1 anti-PVG serum on the day of grafting prevents rejection and induces a state of specific unresponsiveness. An adoptive transfer assay was used to test the capacity of T cell subsets, taken from rats given enhancing serum, to either restore rejection or to transfer unresponsiveness to syngeneic hosts irradiated with 9 Gy and grafted with donor (PVG) or third party (Wistar-Furth) hearts. W3/25+ (CD4+) cells from these animals retained some capacity to restore rejection until 50 days posttransplant, after which they invariably failed to restore PVG graft rejection but retained the capacity to effect Wistar-Furth rejection. At this time CD4+ cells were also capable of inhibiting naive but not specifically sensitized CD4+ cells capacity to restore PVG graft rejection in irradiated hosts. The development of CD4+ suppressor cells was concurrent with the appearance of clinically evident unresponsiveness in the host. MRC Ox8+ (CD8+) cells from enhanced rats when mixed with naive CD4+ cells delayed rejection in adoptive recipients but did not reestablish unresponsiveness. Paradoxically, the CD4+ cells that transfer unresponsiveness to the adoptive host proliferate such as normal cells in MLC to both donor and third party alloantigen. Unfractionated cells, CD4+ or CD8+ cells did not proliferate to relevant idiotype in vitro. The CD4+ cells after 3 days in culture, with either alloantigen or idiotype-bearing stimulator cells, lost their capacity to suppress in the adoptive transfer assay. The maintenance of specific unresponsiveness was thus shown to be due to a CD4+ suppressor T cell whose function was lost in culture, and therefore could not be detected in MLC or idiotype assays.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472441

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats.

Authors:  N Murase; D G Kim; S Todo; D V Cramer; J Fung; T E Starzl
Journal:  Transplantation       Date:  1990-11       Impact factor: 4.939

2.  Mechanisms in passive enhancement of cardiac and renal allografts by serum from liver-grafted rats.

Authors:  A Yamaguchi; N Kamada
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

3.  Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma.

Authors:  R J North; M Awwad
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

4.  Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action.

Authors:  B M Hall; N W Pearce; K E Gurley; S E Dorsch
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

5.  Role of the thymus in transplantation tolerance in miniature swine. I. Requirement of the thymus for rapid and stable induction of tolerance to class I-mismatched renal allografts.

Authors:  K Yamada; P R Gianello; F L Ierino; T Lorf; A Shimizu; S Meehan; R B Colvin; D H Sachs
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

6.  Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients.

Authors:  Nirupama Darshan Verma; Bruce Milne Hall; Karren Michelle Plain; Catherine M Robinson; Rochelle Boyd; Giang T Tran; Chuanmin Wang; G Alex Bishop; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2014-05-09       Impact factor: 7.561

7.  Changes in Reactivity In Vitro of CD4+CD25+ and CD4+CD25- T Cell Subsets in Transplant Tolerance.

Authors:  Bruce M Hall; Catherine M Robinson; Karren M Plain; Nirupama D Verma; Giang T Tran; Masaru Nomura; Nicole Carter; Rochelle Boyd; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2017-08-22       Impact factor: 7.561

8.  Alloactivation of Naïve CD4+CD8-CD25+T Regulatory Cells: Expression of CD8α Identifies Potent Suppressor Cells That Can Promote Transplant Tolerance Induction.

Authors:  Nirupama D Verma; Catherine M Robinson; Nicole Carter; Paul Wilcox; Giang T Tran; Chaunmin Wang; Alexandra Sharland; Masaru Nomura; Karren M Plain; G Alexander Bishop; Suzanne J Hodgkinson; Bruce M Hall
Journal:  Front Immunol       Date:  2019-10-14       Impact factor: 7.561

Review 9.  Transplant Tolerance, Not Only Clonal Deletion.

Authors:  Bruce M Hall; Nirupama D Verma; Giang T Tran; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2022-04-21       Impact factor: 8.786

10.  Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity?

Authors:  Bruce M Hall; Giang T Tran; Nirupama D Verma; Karren M Plain; Catherine M Robinson; Masaru Nomura; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2013-08-02       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.